Immunometabolism in obese asthmatics: Are we there yet?

Nutrients

Volumn 5, Issue 9, 2013, Pages 3506-3530

  Periyalil, Hashim A ^a   Gibson, Peter G ^a,b   Wood, Lisa G ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Asthma; Immunometabolism; Macrophages; Mast cells; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CD163 ANTIGEN; I KAPPA B KINASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; K 877; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADIPOCYTE; ASTHMA; BODY MASS; CELL HYPERPLASIA; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNITY; IMMUNOMETABOLISM; INNATE IMMUNITY; INTRAABDOMINAL FAT; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MAST CELL; METABOLISM; NEUTROPHILIA; NONHUMAN; OBESITY; RESPIRATORY TRACT INFLAMMATION; REVIEW; UNSPECIFIED SIDE EFFECT; WHITE ADIPOSE TISSUE;

MURINAE;

ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTRA-ABDOMINAL FAT; MAST CELLS; OBESITY;

EID: 84884171069     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5093506     Document Type: Review

References (213)

1. Au, N. The health care cost implications of overweight and obesity during childhood. Health Serv. Res. 2012, 47, 655-676.
2. Rodriguez-Hernandez, H.; Simental-Mendia, L.E.; Rodriguez-Ramirez, G.; Reyes-Romero, M.A. Obesity and inflammation: Epidemiology, risk factors, and markers of inflammation. Int. J. Endocrinol. 2013, 2013, 1-11.
3. Block, J.P.; Subramanian, S.V.; Christakis, N.A.; O'Malley, AJ. Population trends and variation in body mass index from 1971 to 2008 in the framingham heart study offspring cohort. PLoS One 2013, 8, e63217.
4. Ali, Z.; Ulrik, C.S. Obesity and asthma: A coincidence or a causal relationship? A systematic review. Respir. Med. 2013, 707, 1287-1300.
5. Mosen, D.M.; Schatz, M.; Magid, DJ.; Camargo, CA., Jr. The relationship between obesity and asthma severity and control in adults. J. Allergy Clin. Immunol. 2008, 122, 507-511.
6. Ford, E.S. The epidemiology of obesity and asthma. J. Allergy Clin. Immunol. 2005, 775, 897-909.
7. Black, M.H.; Smith, N.; Porter, A.H.; Jacobsen, S.J.; Koebnick, C. Higher prevalence of obesity among children with asthma. Obesity (Silver Spring) 2012, 20, 1041-1047.
8. Brumpton, B.; Langhammer, A.; Romundstad, P.; Chen, Y.; Mai, X.M. General and abdominal obesity and incident asthma in adults: The HUNT study. Eur. Respir. J. 2013, 41, 323-329.
9. Saint-Pierre, P.; Bourdin, A.; Chanez, P.; Daures, J.P.; Godard, P. Are overweight asthmatics more difficult to control? Allergy 2006, 61, 79-84.
10. Stream, A.R.; Sutherland, E.R. Obesity and asthma disease phenotypes. Curr. Opin. Allergy Clin. Immunol. 2012, 12, 76-81.
11. Lessard, A.; Turcotte, H.; Cormier, Y.; Boulet, L.P. Obesity and asthma: A specific phenotype? Chest 2008,134, 317-323.
12. Baek, H.S.; Kim, Y.D.; Shin, J.H.; Kim, J.H.; Oh, J.W.; Lee, H.B. Serum leptin and adiponectin levels correlate with exercise-induced bronchoconstriction in children with asthma. Ann. Allergy Asthma Immunol.2011, 107, 14-21.
13. Holguin, F.; Rojas, M.; Brown, L.A.; Fitzpatrick, A.M. Airway and plasma leptin and adiponectin in lean and obese asthmatics and controls. J. Asthma 2011, 48, 217-223.
14. Zerah, F.; Harf, A.; Perlemuter, L.; Lorino, H.; Lorino, A.M.; Atlan, G. Effects of obesity on respiratory resistance. Chest 1993, 103, 1470-1476.
15. Thomsen, S.F.; Ulrik, C.S.; Kyvik, K.O.; Sorensen, T.I.; Posthuma, D.; Skadhauge, L.R.; Steffensen, L; Backer, V. Association between obesity and asthma in a twin cohort. Allergy 2007,62, 1199-1204.
16. Melen, E.; Himes, B.E.; Brehm, J.M.; Boutaoui, N.; Klanderman, B.J.; Sylvia, J.S.; Lasky-Su, J. Analyses of shared genetic factors between asthma and obesity in children. J. Allergy Clin. Immunol. 2010, 126, 631-637.
17. Farah, C.S.; Salome, CM. Asthma and obesity: A known association but unknown mechanism. Respirology 2012, 17, 412-421.
18. Mathis, D.; Shoelson, S.E. Immunometabolism: An emerging frontier. Nat. Rev. Immunol. 2011, 77, doi:10.1038/nri2922.
19. Odegaard, J.I.; Ricardo-Gonzalez, R.R.; Goforth, M.H.; Morel, C.R.; Subramanian, V.; Mukundan, L.; Red Eagle, A.; Vats, D.; Brombacher, F.; Ferrante, A.W. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447, 1116-1120.
20. Divoux, A.; Moutel, S.; Poitou, C; Lacasa, D.; Veyrie, N.; Aissat, A.; Arock, M.; Guerre-Millo, M.; Clement, K. Mast cells in human adipose tissue: Link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Me tab. 2012, 97, E1677-E1685.
21. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
22. Wang, T.N.; Wu, C.C.; Huang, M.S.; Wang, C.C.; Huang, C.C.; Wang, T.H.; Lien, T.C.; Ko, Y.C.; Lin, M.C. The polymorphisms of C-reactive protein gene modify the association between central obesity and lung function in taiwan asthmatics. Scand. J. Immunol. 2011, 74, 482-488.
23. Cheng, S.; Fox, C.S.; Larson, M.G.; Massaro, J.M.; McCabe, EX.; Khan, A.M.; Levy, D.; Hoffmann, U.; O'Donnell, C.J.; Miller, K.K. et al. Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am. J. Cardiol. 2011, 705, 979-984.
24. Li, C; Ford, E.S.; McGuire, L.C.; Mokdad, A.H. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 2007, 15, 216-224.
25. Sideleva, O.; Suratt, B.T.; Black, K.E.; Tharp, W.G; Pratley, R.E.; Forgione, P.; Dienz, O.; Irvin, CG.; Dixon, A.E. Obesity and asthma: An inflammatory disease of adipose tissue not the airway. Am. J. Respir. Crit. Care Med. 2012, 186, 598-605.
26. Sood, A. Obesity, adipokines, and lung disease. J. Appl. Physiol. 2010, 705, 744-753.
27. Harwood, HJ., Jr. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2011, 63, 57-75.
28. Fonseca-Alaniz, M.H.; Takada, J.; Alonso-Vale, M.I.; Lima, F.B. Adipose tissue as an endocrine organ: From theory to practice. J. Pediatr. (RioJ.) 2007, 83, 192-203.
29. Hajer, G.R.; van Haeften, T.W.; Visseren, F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008, 29, 2959-2971.
30. Jo, J.; Gavrilova, O.; Pack, S.; Jou, W.; Mullen, S.; Sumner, A.E.; Cushman, S.W.; Periwal, V. Hypertrophy and/or yperplasia: Dynamics of dipose tissue growth. PLoS Comput. Biol. 2009, 5, el000324.
31. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454, 428-435.
32. Yalcin, A.; Hotamisligil, G.S. Impact of ER protein homeostasis on metabolism. Diabetes 2013, 62, 691-693.
33. Shi, H.; Kokoeva, M.V.; Inouye, K.; Tzameli, I.; Yin, H.; Flier, J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Investig. 2006, 116, 3015-3025.
34. De Nardo, D.; Latz, E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 2011, 32, 373-379.
35. Horng, T.; Hotamisligil, G.S. Linking the inflammasome to obesity-related disease. Nat. Med. 2011, 17, 164-165.
36. Stienstra, R.; Tack, C.J.; Kanneganti, T.D.; Joosten, L.A.; Netea, M.G. The inflammasome puts obesity in the danger zone. CellMetab. 2012, 15, 10-18.
37. Hotamisligil, G.S.; Shargill, N.S.; Spiegelman, B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
38. Uysal, K.T.; Wiesbrock, S.M.; Marino, M.W.; Hotamisligil, G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389, 610-614.
39. Kershaw, E.E.; Flier, J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548-2556.
40. Calay, E.S.; Hotamisligil, G.S. Turning off the inflammatory, but not the metabolic, flames. Nat. Med. 2013, 19, 265-267.
41. Vachharajani, V.; Cunningham, C; Yoza, B.; Carson, J., Jr.; Vachharajani, T.J.; McCall, C. Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity (Silver Spring) 2012, 20, 498-504.
42. Tilg, H.; Moschen, A.R. Role of adiponectin and PBEF/visfatin as regulators of inflammation: Involvement in obesity-associated diseases. Clin. Sei. (Lond.) 2008,114, 275-288.
43. Zarkesh-Esfahani, H.; Pockley, A.G; Wu, Z.; Hellewell, P.G; Weetman, A.P.; Ross, R.J. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J. Immunol. 2004, 172, 1809-1814.
44. Considine, R.V.; Caro, J.F. Leptin and the regulation of body weight. Int. J. Biochem. Cell Biol. 1997, 29, 1255-1272.
45. Caro, J.F.; Sinha, M.K.; Kolaczynski, J.W.; Zhang, P.L.; Considine, R.V. Leptin: The tale of an obesity gene. Diabetes 1996, 45, 1455-1462.
46. Pelleymounter, M.A.; Cullen, M.J.; Baker, M.B.; Hecht, R.; Winters, D.; Boone, T.; Collins, F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269, 540-543.
47. Campfield, L.A.; Smith, F.J.; Guisez, Y.; Devos, R.; Burn, P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269, 546-549.
48. Procaccini, C; Jirillo, E.; Matarese, G. Leptin as an immunomodulator. Mol. Aspects Med. 2012, 33, 35-45.
49. Caldefie-Chezet, F.; Poulin, A.; Vasson, M.P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 2003, 37, 809-814.
50. Bouloumie, A.; Marumo, T.; Lafontan, M.; Busse, R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999, 13, 1231-1238.
51. Allison, M.A.; Ix, J.H.; Morgan, C; McClelland, R.L.; Rifkin, D.; Shimbo, D.; Criqui, M.H. Higher leptin is associated with hypertension: The multi-ethnic study of atherosclerosis. J. Hum. Hypertens. 2013, doi:10.1038/jhh.2013.24.
52. Wang, H.; Luo, W.; Eitzman, D.T. Leptin in thrombosis and atherosclerosis. Curr. Pharm. Des. 2013, in press
53. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257, 79-83.
54. Hu, E.; Liang, P.; Spiegelman, B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 1996, 271, 10697-10703.
55. Kern, P.A.; Di Gregorio, G.B.; Lu, T.; Rassouli, N.; Ranganathan, G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52, 1779-1785.
56. Yang, W.S.; Lee, W.J.; Funahashi, T.; Tanaka, S.; Matsuzawa, Y; Chao, C.L.; Chen, C.L.; Tai, T.Y.; Chuang, L.M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001, 86, 3815-3819.
57. Bruun, J.M.; Lihn, A.S.; Verdich, C; Pedersen, S.B.; Toubro, S.; Astrup, A.; Richelsen, B. Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E527-E533.
58. Utsal, L.; Tillmann, V.; Zilmer, M.; Maestu, J.; Purge, P.; Jurimae, J.; Saar, M.; Latt, E.; Maasalu, K.; Jurimae, T. Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-gamma levels in 10-to 11-year-old boys with increased BMI. Horm. Res. Paediatr. 2012, 78, 31-39.
59. Ajuwon, K.M.; Spurlock, M.E. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J. Nutr. 2005, 135, 1841-1846.
60. Cook, D.G; Mendall, M.A.; Whincup, P.H.; Carey, I.M.; Ballam, L.; Morris, J.E.; Miller, G.J.; Strachan, D.P. C-reactive protein concentration in children: Relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000,149, 139-150.
61. Warnberg, J.; Moreno, L.A.; Mesana, M.I.; Marcos, A. Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study. Int. J. Obes. Relat. Metab. Disord. 2004, 25(Suppl. 3), 59-63.
62. Rawson, E.S.; Freedson, P.S.; Osganian, S.K.; Matthews, C.E.; Reed, G.; Ockene, IS. Body mass index, but not physical activity, is associated with C-reactive protein. Med. Sei. Sports Exerc. 2003, 35, 1160-1166.
63. Rommel, J.; Simpson, R.; Mounsey, J.P.; Chung, E.; Schwartz, J.; Pursell, I.; Gehi, A. Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am. J. Cardiol. 2013, 111, 208-212.
64. Cinti, S.; Mitchell, G.; Barbatelli, G.; Murano, I.; Ceresi, E.; Faloia, E.; Wang, S.; Fortier, M.; Greenberg, A.S.; Obin, M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46, 2347-2355.
65. Suganami, T.; Ogawa, Y. Adipose tissue macrophages: Their role in adipose tissue remodeling. J. Leukoc. Biol. 2010, 88, 33-39.
66. Cancello, R.; Tordjman, J.; Poitou, C; Guilhem, G.; Bouillot, J.L.; Hugol, D.; Coussieu, C; Basdevant, A.; Bar Hen, A.; Bedossa, P. et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006,55, 1554-1561.
67. Nishimura, S.; Manabe, I.; Nagasaki, M.; Seo, K.; Yamashita, H.; Hosoya, Y.; Ohsugi, M.; Tobe, K.; Kadowaki, T.; Nagai, R. et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J. Clin. Investig. 2008, 118, 710-721.
68. Xu, H.; Barnes, G.T.; Yang, Q.; Tan, G; Yang, D.; Chou, C.J.; Sole, J.; Nichols, A.; Ross, J.S.; Tartaglia, L.A. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003, 112, 1821-1830.
69. Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 2003, 112, 1796-1808.
70. Riordan, N.H.; Ichim, T.E.; Min, W.P.; Wang, H.; Solano, F.; Lara, F.; Alfaro, M.; Rodriguez, J.P.; Harman, R.J.; Patel A.N et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J. Transl. Med. 2009, 7, doi:10.1186/1479-5876-7-29.
71. Schipper, H.S.; Prakken, B.; Kalkhoven, E.; Boes, M. Adipose tissue-resident immune cells: Key players in immunometabolism. Trends Endocrinol. Metab. 2012, 23, 407-415.
72. Duewell, P.; Kono, H.; Rayner, K.J.; Sirois, CM.; Vladimer, G; Bauernfeind, F.G; Ábela, G.S.; Franchi, L.; Nunez, G.; Schnurr, M. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464, 1357-1361.
73. Vandanmagsar, B.; Youm, Y.H.; Ravussin, A.; Galgani, J.E.; Stadler, K.; Mynatt, R.L.; Ravussin, E.; Stephens, J.M.; Dixit, V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17, 179-188.
74. Strissel, K.J.; Stancheva, Z.; Miyoshi, H.; Perfield, J.W., II; DeFuria, J.; Jick, Z.; Greenberg, A.S.; Obin, M.S. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 5 5, 2910-2918.
75. Alkhouri, N.; Gornicka, A.; Berk, M.P.; Thapaliya, S.; Dixon, L.J.; Kashyap, S.; Schauer, P.R.; Feldstein, A.E. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. 2010, 285, 3428-3438.
76. Tordjman, J.; Poitou, C; Hugol, D.; Bouillot, J.L.; Basdevant, A.; Bedossa, P.; Guerre-Millo, M.; Clement, K. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: Influence of glycemic status. J. Hepatol 2009, 51, 354-362.
77. Abreu Velez, A.M.; Dejoseph, L.M.; Howard, M.S. HAM56 and CD68 antigen presenting cells surrounding a sarcoidal granulomatous tattoo. iV. Am. J. Med. Sei. 2011, 3, 475-477
78. Sethi, J.K.; Vidal-Puig, A.J. Thematic review series: Adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 2007, 48, 1253-1262.
79. Osborn, O.; Olefsky, J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18, 363-374.
80. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: Tumor-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23, 549-555.
81. Sica, A.; Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Investig. 2012, 122, 787-795.
82. Mosser, D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73, 209-212.
83. Biswas, S.K.; Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 2010, 77, 889-896.
84. Chinetti-Gbaguidi, G.; Staels, B. Macrophage polarization in metabolic disorders: Functions and regulation. Curr. Opin. Lipidol. 2011, 22, 365-372.
85. Cairo, G.; Recalcati, S.; Mantovani, A.; Locati, M. Iron trafficking and metabolism in macrophages: Contribution to the polarized phenotype. Trends Immunol. 2011, 32, 241-247.
86. Martinez, F.O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006, 777, 7303-7311.
87. Rodriguez-Prados, J.C.; Traves, P.G.; Cuenca, J.; Rico, D.; Aragones, J.; Martin-Sanz, P.; Cascante, M.; Bosca, L. Substrate fate in activated macrophages: A comparison between innate, classic, and alternative activation. J. Immunol. 2010, 755, 605-614.
88. Van Gool, F.; Galii, M.; Gueydan, C; Kruys, V.; Prevot, P.P.; Bedalov, A.; Mostoslavsky, R.; Alt, F.W.; de Smedt, T.; Leo, O. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat. Med. 2009, 15, 206-210.
89. Van den Heuvel, M.M.; Tensen, C.P.; van As, J.H.; van den Berg, T.K.; Fluitsma, D.M.; Dijkstra, CD.; Dopp, E.A.; Droste, A.; van Gaalen, F.A.; Sorg, C et al. Regulation of CD 163 on human macrophages: Cross-Linking of CD 163 induces signaling and activation. J. Leukoc. Biol. 1999, 66, 858-866.
90. Möller, H.J. Soluble CD 163. Scand. J. Clin. Lab. Investig. 2012, 72, 1-13.
91. Buechler, C; Ritter, M.; Orso, E.; Langmann, T.; Klucken, J.; Schmitz, G. Regulation of scavenger receptor CD 163 expression in human monocytes and macrophages by pro-and antiinflammatory stimuli. J. Leukoc. Biol. 2000, 67, 97-103.
92. Burdo, T.H.; Lo, J.; Abbara, S.; Wei, J.; DeLelys, M.E.; Preffer, F.; Rosenberg, E.S.; Williams, K.C.; Grinspoon, S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J. Infect. Dis. 2011, 204, 1227-1236.
93. Knudsen, T.B.; Larsen, K.; Kristiansen, T.B.; Moller, HJ.; Tvede, M.; Eugen-Olsen, J.; Kronborg, G. Diagnostic value of soluble CD 163 serum levels in patients suspected of meningitis: Comparison with CRP and procalcitonin. Scand. J. Infect. Dis. 2007, 39, 542-553.
94. Fjeldborg, K.; Christiansen, T.; Bennetzen, M.; Moller, HJ.; Pedersen, S.B.; Richelsen, B. The macrophage specific serum marker, soluble CD 163, is increased in obesity and reduced after dietary induced weight loss. Obesity (Silver Spring) 2013, doi: 10.1002/oby.20376.
95. Al-Daghri, N.M.; AI-Attas, O.S.; Bindahman, L.S.; Alokail, M.S.; Alkharfy, K.M.; Draž, H.M.; Yakout, S.; McTernan, P.G.; Sabico, S.; Chrousos, G.P. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. Eur. J. Clin. Investig. 2012, 42, 1221-1226.
96. Moestrup, S.K.; Moller, HJ. CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 2004, 36, 347-354.
97. Van Gorp, H.; Delputte, P.L.; Nauwynck, HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol. Immunol. 2010, 47, 1650-1660.
98. Fabriek, B.O.; Dijkstra, CD.; van den Berg, T.K. The macrophage scavenger receptor CD163. Immunobiology 2005, 210, 153-160.
99. Kristiansen, M.; Graversen, J.H.; Jacobsen, C; Sonne, O.; Hoffman, HJ.; Law, S.K.; Moestrup, S.K. Identification of the haemoglobin scavenger receptor. Nature 2001, 409, 198-201.
100. Backe, E.; Schwarting, R.; Gerdes, J.; Ernst, M.; Stein, H. Ber-MAC3: New monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J. Clin. Pathol. 1991, 44, 936-945.
101. Parkner, T.; Sorensen, L.P.; Nielsen, A.R.; Fischer, C.P.; Bibby, B.M.; Nielsen, S.; Pedersen, B.K.; Moller, HJ. Soluble CD163: A biomarker linking macrophages and insulin resistance. Diabetologia 2012, 55, 1856-1862.
102. Yin, M.J.; Yamamoto, Y.; Gaynor, R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396, 77-80.
103. Apovian, CM.; Bigornia, S.; Mott, M.; Meyers, M.R.; Ulloor, J.; Gagua, M.; McDonnell, M.; Hess, D.; Joseph, L.; Gokce, N. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler. Thromb. Vase. Biol. 2008, 28, 1654-1659.
104. Henao-Mejia, J.; Elinav, E.; Jin, C; Hao, L.; Mehal, W.Z.; Strowig, T.; Thaiss, CA.; Kau, A.L.; Eisenbarth, S.C; Jurczak, M.J.; et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482, 179-185.
105. Axelsson, J.; Moller, HJ.; Witasp, A.; Qureshi, A.R.; Carrero, J.J.; Heimburger, O.; Barany, P.; Alvestrand, A.; Lindholm, B.; Moestrup, S.K. et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am. J. Kidney Dis. 2006, 48, 916-925.
106. Metcalfe, D.D.; Baram, D.; Mekori, Y.A. Mast cells. Physiol. Rev. 1997, 77, 1033-1079.
107. Liu, J.; Divoux, A.; Sun, J.; Zhang, J.; Clement, K.; Glickman, J.N.; Sukhova, G.K.; Wolters, P.J.; Du, J.; Gorgun, C.Z. et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009,15, 940-945.
108. Liu, J.; Divoux, A.; Sun, J.; Zhang, J.; Clement, K.; Glickman, J.N.; Sukhova, G.K.; Wolters, P.J.; Du, J.; Gorgun, C.Z. et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009,15, 940-945.
109. Payne, V.; Kam, P.C. Mast cell tryptase: A review of its physiology and clinical significance. Anaesthesia 2004, 59, 695-703.
110. Komarow, H.D.; Hu, Z.; Brittain, E.; Uzzaman, A.; Gaskins, D.; Metcalfe, D.D. Serum tryptase levels in atopic and nonatopic children. J. Allergy Clin. Immunol. 2009, 124, 845-848.
111. Gonzalez-Quintela, A.; Vizcaino, L.; Gude, F.; Rey, J.; Meijide, L.; Fernandez-Merino, C; Linneberg, A.; Vidal, C. Factors influencing serum total tryptase concentrations in a general adult population. Clin. Chem. Lab. Med. 2010, 48, 701-706.
112. Fenger, R.V.; Linneberg, A.; Vidal, C; Vizcaino, L.; Husemoen, L.L.; Aadahl, M.; Gonzalez-Quintela, A. Determinants of serum tryptase in a general population: The relationship of serum tryptase to obesity and asthma. Int. Arch. Allergy Immunol. 2012, 157, 151-158.
113. Seidell, J.C; de Groot, L.C; van Sonsbeek, J.L.; Deurenberg, P.; Hautvast, J.G. Associations of moderate and severe overweight with self-reported illness and medical care in Dutch adults. Am. J. Public Health 1986, 76, 264-269.
114. Negri, E.; Pagano, R.; Decarli, A.; La Vecchia, C. Body weight and the prevalence of chronic diseases. J. Epidemiol. Community Health 1988, 42, 24-29.
115. Shaheen, S.O.; Sterne, J.A.; Montgomery, S.M.; Azima, H. Birth weight, body mass index and asthma in young adults. Thorax 1999, 54, 396-402.
116. Beuther, D.A.; Sutherland, E.R. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologie studies. Am. J. Respir. Crit. Care Med. 2007, 175, 661-666.
117. Chen, Y.; Dales, R.; Tang, M.; Krewski, D. Obesity may increase the incidence of asthma in women but not in men: Longitudinal observations from the Canadian National Population Health Surveys. Am. J. Epidemiol. 2002, 755, 191-197.
118. Haldar, P.; Pavord, I.D.; Shaw, D.E.; Berry, M.A.; Thomas, M.; Brightling, C.E.; Wardlaw, A.J.; Green, R.H. Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 2008,775,218-224.
119. Moore, W.C; Meyers, D.A.; Wenzel, S.E.; Teague, W.G; Li, H.; Li, X.; D'Agostino, R., Jr.; Castro, M.; Curran-Everett, D.; Fitzpatrick, A.M. et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 2010,757,315-323.
120. Camargo, CA., Jr.; Weiss, S.T.; Zhang, S.; Willett, W.C; Speizer, F.E. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch. Intern. Med. 1999, 759, 2582-2588.
121. Gold, D.R.; Damokosh, A.I.; Dockery, D.W.; Berkey, C.S. Body-mass index as a predictor of incident asthma in a prospective cohort of children. Pediatr. Pulmonol. 2003, 36, 514-521.
122. Bergen, H.T.; Cherlet, T.C.; Manuel, P.; Scott, J.E. Identification of leptin receptors in lung and isolated fetal type II cells. Am. J. Respir. Cell Mol. Biol. 2002, 27, 71-77.
123. Bruno, A.; Pace, E.; Chanez, P.; Gras, D.; Vachier, I.; Chiappara, G.; La Guardia, M.; Gerbino, S.; Profita, M.; Gjomarkaj, M. Leptin and leptin receptor expression in asthma. J. Allergy Clin. Immunol. 2009, 124, 230-237.
124. Hug, C; Wang, J.; Ahmad, N.S.; Bogan, J.S.; Tsao, T.S.; Lodish, H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sei. USA 2004, 707, 10308-10313.
125. Mancuso, P.; Huffnagle, G.B.; Olszewski, M.A.; Phipps, J.; Peters-Golden, M. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 2006, 173, 212-218.
126. Sideleva, O.; Suratt, B.T.; Black, K.E.; Tharp, W.G; Pratley, R.E.; Forgione, P.; Dienz, O.; Irvin, CG.; Dixon, A.E. Obesity and Asthma: An Inflammatory Disease of Adipose Tissue Not the Airway. Am. J. Respir. Crit. Care Med. 2012, 186, 598-605.
127. Kim, K.W.; Shin, Y.H.; Lee, K.E.; Kim, E.S.; Sohn, M.H.; Kim, K.E. Relationship between adipokines and manifestations of childhood asthma. Pediatr. Allergy Immunol. 2008,19, 535-540.
128. Sood, A.; Ford, E.S.; Camargo, CA., Jr. Association between leptin and asthma in adults. Thorax 2006, 61, 300-305.
129. Sood, A.; Cui, X.; Quails, C; Beckett, W.S.; Gross, M.D.; Steffes, M.W.; Smith, L.J.; Jacobs, D.R., Jr. Association between asthma and serum adiponectin concentration in women. Thorax 2008, 63, 877-882.
130. Schols, A.M.; Creutzberg, E.C.; Buurman, W.A.; Campfield, L.A.; Saris, W.H.; Wouters, E.F. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999, 160, 1220-1226.
131. Guler, N.; Kirerlen, E.; Ones, U.; Tamay, Z.; Salmayenli, N.; Darendeliler, F. Leptin: Does it have any role in childhood asthma? J. Allergy Clin. Immunol. 2004, 114, 254-259.
132. Johnston, R.A.; Schwartzman, I.N.; Shore, S.A. Macrophage inflammatory protein-2 levels are associated with changes in serum leptin concentrations following ozone-induced airway inflammation. Chest 2003, 123, 369S-370S.
133. Wood, L.G.; Gibson, P.G. Adiponectin: The link between obesity and asthma in women? Am. J. Respir. Crit. Care Med. 2012, 186, 1-2.
134. Tsaroucha, A.; Daniil, Z.; Malli, F.; Georgoulias, P.; Minas, M.; Kostikas, K.; Bargiota, A.; Zintzaras, E.; Gourgoulianis, K.I. Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods. J. Asthma 2013, 50, 188-197.
135. Shore, S.A.; Terry, R.D.; Flynt, L.; Xu, A.; Hug, C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 2006, 118, 389-395.
136. Summer, R.; Little, F.F.; Ouchi, N.; Takemura, Y.; Aprahamian, T.; Dwyer, D.; Fitzsimmons, K.; Suki, B.; Parameswaran, H.; Fine, A. et al. Alveolar macrophage activation and an emphysemalike phenotype in adiponectin-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, L1035-L1042.
137. Sood, A.; Ford, E.S.; Camargo, CA., Jr. Association between leptin and asthma in adults. Thorax 2006, 61, 300-305.
138. Sood, A.; Cui, X.; Quails, C; Beckett, W.S.; Gross, M.D.; Steffes, M.W.; Smith, L.J.; Jacobs, D.R., Jr. Association between asthma and serum adiponectin concentration in women. Thorax 2008, 63, 877-882.
139. Sood, A.; Dominic, E.; Quails, C; Steffes, M.W.; Thyagarajan, B.; Smith, L.J.; Lewis, C.E.; Jacobs, D.R., Jr. Serum adiponectin is associated with adverse outcomes of asthma in men but not in women. Front. Pharmacol. 2011, 2, doi:10.3389/fphar.2011.00055
140. Sato, H.; Sugai, H.; Kurosaki, H.; Ishikawa, M.; Funaki, A.; Kimura, Y.; Ueno, K. The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes. Biol. Pharm. Bull. 2013, 36, 564-573.
141. Wildman, R.P.; Wang, D.; Fernandez, I.; Mancuso, P.; Santoro, N.; Scherer, P.E.; Sowers, M.R. Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) 2013, 21, 629-636.
142. Zanni, M.V.; Burdo, T.H.; Makimura, H.; Williams, K.C.; Grinspoon, S.K. Relationship between monocyte/macrophage activation marker soluble CD 163 and insulin resistance in obese and normal-weight subjects. Clin. Endocrinol. (Oxf.) 2012, 77, 385-390.
143. Sismanopoulos, N.; Delivanis, D.A.; Mavrommati, D.; Hatziagelaki, E.; Conti, P.; Theoharides, T.C. Do mast cells link obesity and asthma? Allergy 2012, 68, 8-15.
144. Brightling, C.E.; Bradding, P.; Symon, F.A.; Holgate, S.T.; Wardlaw, A.J.; Pavord, I.D. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002, 346, 1699-1705.
145. Hogan, A.D.; Schwartz, L.B. Markers of mast cell degranulation. Methods 1997, 13, 43-52.
146. Sutcliffe, A.; Kaur, D.; Page, S.; Woodman, L.; Armour, C.L.; Baraket, M.; Bradding, P.; Hughes, J.M.; Brightling, C.E. Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax 2006, 61, 657-662.
147. Balzar, S.; Fajt, M.L.; Comhair, S.A.; Erzurum, S.C.; Bleecker, E.; Busse, W.W.; Castro, M.; Gaston, B.; Israel, E.; Schwartz, L.B. et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 2011, 183, 299-309.
148. Bradding, P.; Walls, A.F.; Holgate, S.T. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006, 117, 1277-1284.
149. Brown, J.K.; Jones, CA.; Tyler, C.L.; Ruoss, S.J.; Hartmann, T.; Caughey, G.H. Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest 1995, 707, 95S-96S.
150. Panettieri, R.A.; Tan, E.M.; Ciocca, V.; Luttmann, M.A.; Leonard, T.B.; Hay, D.W. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 1998, 19, 453-461.
151. Gibson, P.G.; Saltos, N.; Borgas, T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J. Allergy Clin. Immunol. 2000, 105, 752-759.
152. Koshino, T.; Teshima, S.; Fukushima, N.; Takaishi, T.; Hirai, K.; Miyamoto, Y.; Arai, Y.; Sano, Y.; Ito, K.; Morita, Y. Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin. Exp. Allergy 1993, 23, 919-925.
153. Carroll, N.G.; Mutavdzic, S.; James, A.L. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002, 57, 677-682.
154. Wood, L.G.; Gibson, P.G. Dietary factors lead to innate immune activation in asthma. Pharmacol. Ther. 2009, 123, 37-53.
155. Kharitonov, S.A.; Yates, D.; Springall, D.R.; Buttery, L.; Polak, J.; Robbins, R.A.; Barnes, P.J. Exhaled nitric oxide is increased in asthma. Chest 1995, 707, 156S-157S.
156. Kazaks, A.; Uriu-Adams, J.Y.; Stern, J.S.; Albertson, T.E. No significant relationship between exhaled nitric oxide and body mass index in people with asthma. J. Allergy Clin. Immunol. 2005, 116, 929-930.
157. Leung, T.F.; Li, C.Y.; Lam, C.W.; Au, C.S.; Yung, E.; Chan, I.H.; Wong, GW.; Fok, T.F. The relation between obesity and asthmatic airway inflammation. Pediatr. Allergy Immunol. 2004, 15, 344-350.
158. Van Veen, I.H.; Ten Brinke, A.; Sterk, P.J.; Rabe, K.F.; Bel, E.H. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008, 63, 570-574.
159. Jensen, M.E.; Collins, C.E.; Gibson, P.G.; Wood, L.G. The obesity phenotype in children with asthma. Paediatr. Respir. Rev. 2011, 12, 152-159.
160. Von Mutius, E.; Schwartz, J.; Neas, L.M.; Dockery, D.; Weiss, S.T. Relation of body mass index to asthma and atopy in children: The National Health and Nutrition Examination Study III. Thorax 2001, 56, 835-838.
161. Hashimoto, C; Hudson, K.L.; Anderson, K.V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52, 269-279.
162. Ghanim, H.; Sia, C.L.; Upadhyay, M.; Korzeniewski, K.; Viswanathan, P.; Abuaysheh, S.; Mohanty, P.; Dandona, P. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am. J. Clin. Nutr. 2010, 91, 940-949.
163. Patel, C; Ghanim, H.; Ravishankar, S.; Sia, C.L.; Viswanathan, P.; Mohanty, P.; Dandona, P. Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J. Clin. Endocrinol. Metab. 2007, 92, 4476-4479.
164. Blackburn, P.; Despres, J.P.; Lamarche, B.; Tremblay, A.; Bergeron, J.; Lemieux, L; Couillard, C. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 2006, 14, 1747-1754.
165. Wiesner, P.; Choi, S.H.; Almazan, F.; Benner, C; Huang, W.; Diehl, C.J.; Gonen, A.; Butler, S.; Witztum, J.L.; Glass, C.K. et al. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ. Res. 2010, 707, 56-65.
166. Rosenkranz, S.K.; Townsend, D.K.; Steffens, S.E.; Harms, C.A. Effects of a high-fat meal on pulmonary function in healthy subjects. Eur. J. Appl. Physiol. 2010, 109, 499-506.
167. Wood, L.G.; Garg, M.L.; Gibson, P.G. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J. Allergy Clin. Immunol. 2011, 127, 1133-1140.
168. Zhao, L.; Kwon, M.J.; Huang, S.; Lee, J.Y.; Fukase, K.; Inohara, N.; Hwang, D.H. Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J. Biol. Chem. 2007, 282, 11618-11628.
169. Wood, L.G.; Garg, M.L.; Smart, J.M.; Scott, H.A.; Barker, D.; Gibson, P.G. Manipulating antioxidant intake in asthma: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 96, 534-543.
170. Wood, L.G.; Garg, M.L.; Powell, H.; Gibson, P.G. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: Proof of concept. Free Radic. Res. 2008, 42, 94-102.
171. Todd, D.C.; Armstrong, S.; D'Silva, L.; Allen, C.J.; Hargreave, F.E.; Parameswaran, K. Effect of obesity on airway inflammation: A cross-sectional analysis of body mass index and sputum cell counts. Clin. Exp. Allergy 2001, 37, 1049-1054.
172. Wood, L.G.; Baines, K.J.; Fu, J.; Scott, H.A.; Gibson, P.G. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012, 142, 86-93.
173. Telenga, E.D.; Tideman, S.W.; Kerstjens, H.A.; Hacken, N.H.; Timens, W.; Postma, D.S.; van den Berge, M. Obesity in asthma: More neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 2012, 67, 1060-1068.
174. Scott, H.A.; Gibson, P.G.; Garg, M.L.; Wood, L.G. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur. Respir. J. 2011, 38, 594-602.
175. Peters-Golden, M.; Swern, A.; Bird, S.S.; Hustad, CM.; Grant, E.; Edelman, J.M. Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 2006, 27, 495-503.
176. Boulet, L.P.; Franssen, E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir. Med. 2007, 101, 2240-2247.
177. Scott, H.A.; Gibson, P.G.; Garg, M.L.; Wood, L.G. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur. Respir. J. 2011, 38, 594-602.
178. McLachlan, C.R.; Poulton, R.; Car, G; Cowan, J.; Filsell, S.; Greene, J.M.; Taylor, D.R.; Welch, D.; Williamson, A.; Sears, M.R.; et al Adiposity, asthma, and airway inflammation. J. Allergy Clin. Immunol. 2007, 119, 634-639.
179. Woods, S.C; Gotoh, K.; Clegg, DJ. Gender differences in the control of energy homeostasis. Exp. Biol. Med. 2003, 228, 1175-1180.
180. Van Harmelen, V.; Reynisdottir, S.; Eriksson, P.; Thörne, A.; Hoffstedt, J.; Lönnqvist, F.; Arner, P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998, 47, 913-917.
181. Troisi, R.J.; Speizer, F.E.; Willett, W.C; Trichopoulos, D.; Rosner, B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am. J. Respir. Crit. Care Med. 1995, 152, 1183-1188.
182. Fitzpatrick, A.M.; Holguin, F.; Teague, W.G.; Brown, L.A. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J. Allergy Clin. Immunol. 2008, 121, 1372-1378.e3, doi:10.1016/j.jaci.2008.03.008.
183. Marguet, C; Jouen-Boedes, F.; Dean, T.P.; Warner, J.O. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am. J. Respir. Crit. Care Med. 1999, 159, 1533-1540.
184. Lugogo, N.L.; Hollingsworth, J.W.; Howell, D.L.; Que, L.G; Francisco, D.; Church, T.D.; Potts-Kant, E.N.; Ingram, J.L.; Wang, Y.; Jung, S.H.; Kraft, M. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am. J. Respir. Crit. Care Med. 2012, 186, 404-411.
185. Lugogo, N.L.; Hollingsworth, J.W.; Howell, D.L.; Que, L.G.; Francisco, D.; Church, T.D.; Potts-Kant, E.N.; Ingram, J.L.; Wang, Y.; Jung, S.H. et al. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am. J. Respir. Crit. Care Med. 2012, 186, 404-411.
186. Fernandez-Boyanapalli, R.; Goleva, E.; Kolakowski, C; Min, E.; Day, B.; Leung, D.Y.; Riches, D.W.; Bratton, D.L.; Sutherland, E.R. Obesity impairs apoptotic cell clearance in asthma. J. Allergy Clin. Immunol. 2013, 131, 1041-1047.e3, doi:10.1016/j.jaci.2012.09.028.
187. Zhang, Y.; Berger, A.; Milne, CD.; Paige, CJ. Tachykinins in the immune system. Curr. Drug Targets 2006, 7, 1011-1020.
188. Ramalho, R.; Almeida, J.; Beltrao, M.; Pirraco, A.; Costa, R.; Sokhatska, O.; Guardao, L.; Palmares, C; Guimaraes, J.T.; Delgado, L. et al. Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesity-asthma association? Exp. Lung Res. 2012, 38, 316-324.
189. Lavoie, K.L.; Bacon, S.L.; Labrecque, M.; Cartier, A.; Ditto, B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir. Med. 2006, 100, 648-657.
190. Bluher, S.; Moschos, S.; Bullen, J., Jr.; Kokkotou, E.; Maratos-Flier, E.; Wiegand, S.J.; Sleeman, M.W.; Mantzoros, C.S. Ciliary neurotrophic factorAxl5 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 2004, 53, 2787-2796.
191. Ettinger, M.P.; Littlejohn, T.W.; Schwartz, S.L.; Weiss, S.R.; Mcllwain, H.H.; Heymsfield, S.B.; Bray, G.A.; Roberts, W.G.; Heyman, E.R.; Stambler, N. et al. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: A randomized, dose-ranging study. JAMA 2003, 289, 1826-1832.
192. Chida, D.; Osaka, T.; Hashimoto, O.; Iwakura, Y. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 2006, 55, 971-977
193. Evans, R.M.; Barish, G.D.; Wang, Y.X. PPARs and the complex journey to obesity. Nat. Med. 2004,70,355-361.
194. Chawla, A.;Repa, J.J.; Evans, R.M.; Mangelsdorf, DJ. Nuclear receptors and lipid physiology: Opening the X-files. Science 2001, 294, 1866-1870.
195. Lee, C.H.; Chawla, A.; Urbiztondo, N.; Liao, D.; Boisvert, W.A.; Evans, R.M.; Curtiss, L.K. Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta. Science 2003, 302, 453-457.
196. Vats, D.; Mukundan, L.; Odegaard, J.I.; Zhang, L.; Smith, K.L.; Morel, C.R.; Wagner, R.A.; Greaves, D.R.; Murray, P.J.; Chawla, A. Oxidative metabolism and PGC-lbeta attenuate macrophage-mediated inflammation. CellMetab. 2006, 4, 13-24.
197. Kubota, N.; Terauchi, Y.; Kubota, T.; Kumagai, H.; Itoh, S.; Satoh, H.; Yano, W.; Ogata, H.; Tokuyama, K.; Takamoto, I et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and-independent pathways. J. Biol. Chem. 2006, 281, 8748-8755.
198. Yamauchi, T.; Waki, H.; Kamon, J.; Murakami, K.; Motojima, K.; Komeda, K.; Miki, H.; Kubota, N.; Terauchi, Y.; Tsuchida, A. et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Investig. 2001,108, 1001-10137.
199. Jones, J.R.; Barrick, C; Kim, K.A.; Lindner, J.; Blondeau, B.; Fujimoto, Y.; Shiota, M.; Kesterson, R.A.; Kahn, B.B.; Magnuson, M.A. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc. Natl. Acad. Sei. USA 2005, 102, 6207-6712.
200. Yamauchi, T.; Waki, H.; Kamon, J.; Murakami, K.; Motojima, K.; Komeda, K.; Miki, H.; Kubota, N.; Terauchi, Y.; Tsuchida, A. et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Investig. 2001, 108, 1001-1013.
201. Luo, W.; Cao, J.; Li, J.; He, W. Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress. Exp. Gerontol. 2008, 43, 154-163.
202. Bojic, L.A.; Sawyez, CG; Telford, D.E.; Edwards, J.Y.; Hegele, R.A.; Huff, M.W. Activation of peroxisome proliferator-activated receptor delta inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein. Arterioscler. Thromb. Vase. Biol. 2012, 32, 2919-2928.
203. Fruchart, J.C.; Duriez, P. Mode of action of fibrates in the regulation of triglyceride and FIDL-cholesterol metabolism. Drugs Today (Bare.) 2006, 42, 39-64.
204. Harano, Y.; Miyawaki, T.; Nabiki, J.; Shibachi, M.; Adachi, T.; Ikeda, M.; Ueda, F.; Nakano, T. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr. J. 2006, 53, 173-180.
205. Zhang, A.; Sun, H.; Wang, X. Power of metabolomics in biomarker discovery and mining mechanisms of obesity. Obes. Rev. 2012, 14, 344-349.
206. Ament, Z.; Masoodi, M.; Griffin, J.L. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer. Genome Med. 2012, 4, doi:10.1186/gm331
207. Graversen, J.H.; Madsen, M.; Moestrup, S.K. CD163: A signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int. J. Biochem. CellBiol. 2002, 34, 309-314.
208. De Groot, D.M.; Vogel, G.; Dulos, J.; Teeuwen, L.; Stebbins, K.; Hamann, J.; Owens, B.M.; van Eenennaam, H.; Bos, E.; Boots, A.M. Therapeutic antibody targeting of CD97 in experimental arthritis: The role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2. J. Immunol. 2009, 183, 4127-4134.
209. Altintas, M.M.; Azad, A.; Nayer, B.; Contreras, G.; Zaias, J.; Faul, C; Reiser, J.; Nayer, A. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 2011, 52, 480-488.
210. Theoharides, T.C.; Cochrane, D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 2004, 146, 1-12.
211. Vieira Dos Santos, R.; Magerl, M.; Martus, P.; Zuberbier, T.; Church, M.K.; Escribano, L.; Maurer, M. Topical sodium cromoglicate relieves allergen-and histamine-induced dermal pruritus. Br. J. Dermatol. 2010, 162, 674-676.
212. Okayama, Y.; Benyon, R.C.; Rees, P.H.; Lowman, M.A.; Hillier, K.; Church, M.K. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin. Exp. Allergy 1992, 22, 401-409.
213. Fox, C.C; Wolf, E.J.; Kagey-Sobotka, A.; Lichtenstein, L.M. Comparison of human lung and intestinal mast cells. J. Allergy Clin. Immunol. 1988, 81, 89-94.